{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:40:58Z","timestamp":1791499258991,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/leu.2017.16","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T07:41:58Z","timestamp":1484552518000},"page":"2161-2171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT"],"prefix":"10.1038","volume":"31","author":[{"given":"M","family":"Neuenhahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Odendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Schlott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"D\u00f6ssinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lakshmipathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bunjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Harsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Weissinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Uharek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Germeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bonig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G U","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFleu201716_CR1","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/bmt.2014.55","volume":"49","author":"JR Passweg","year":"2014","unstructured":"Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014; 49: 744\u2013750.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu201716_CR2","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","volume":"113","author":"W Zhou","year":"2009","unstructured":"Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins G, Thao L et al. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood 2009; 113: 6465\u20136476.","journal-title":"Blood"},{"key":"BFleu201716_CR3","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","volume":"116","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116: 4360\u20134367.","journal-title":"Blood"},{"key":"BFleu201716_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038\u20131044.","journal-title":"N Engl J Med"},{"key":"BFleu201716_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.20040613","volume":"202","author":"M Cobbold","year":"2005","unstructured":"Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202: 379\u2013386.","journal-title":"J Exp Med"},{"key":"BFleu201716_CR6","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","volume":"99","author":"H Einsele","year":"2002","unstructured":"Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, L\u00f6ffler J et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99: 3916\u20133922.","journal-title":"Blood"},{"key":"BFleu201716_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","volume":"124","author":"C Stemberger","year":"2014","unstructured":"Stemberger C, Graef P, Odendahl M, Albrecht J, D\u00f6ssinger G, Anderl F et al. Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy. Blood 2014; 124: 628\u2013637.","journal-title":"Blood"},{"key":"BFleu201716_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/ciq042","volume":"52","author":"KS Peggs","year":"2011","unstructured":"Peggs KS, Thomson K, Samuel E, Dyer G, Armoogum J, Chakraverty R et al. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin Infect Dis 2011; 52: 49\u201357.","journal-title":"Clin Infect Dis"},{"key":"BFleu201716_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nm0602-631","volume":"8","author":"M Knabel","year":"2002","unstructured":"Knabel M, Franz TJ, Schiemann M, Wulf A, Villmow B, Schmidt B et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med 2002; 8: 631\u2013637.","journal-title":"Nat Med"},{"key":"BFleu201716_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","volume":"51","author":"A Schmitt","year":"2011","unstructured":"Schmitt A, Tonn T, Busch DH, Grigoleit GU, Einsele H, Odendahl M et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 2011; 51: 591\u2013599.","journal-title":"Transfusion"},{"key":"BFleu201716_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jcyt.2014.05.023","volume":"16","author":"M Odendahl","year":"2014","unstructured":"Odendahl M, Grigoleit GU, B\u00f6nig H, Neuenhahn M, Albrecht J, Anderl F et al. Clinical-scale isolation of \u2018minimally manipulated\u2019 cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease. Cytotherapy 2014; 16: 1245\u20131256.","journal-title":"Cytotherapy"},{"key":"BFleu201716_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2007.10.012","volume":"27","author":"C Stemberger","year":"2007","unstructured":"Stemberger C, Huster KM, Koffler M, Anderl F, Schiemann M, Wagner H et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 2007; 27: 985\u2013997.","journal-title":"Immunity"},{"key":"BFleu201716_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2014.05.018","volume":"41","author":"P Graef","year":"2014","unstructured":"Graef P, Buchholz VR, Stemberger C, Flossdorf M, Henkel L, Schiemann M et al. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. Immunity 2014; 41: 116\u2013126.","journal-title":"Immunity"},{"key":"BFleu201716_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.1235454","volume":"340","author":"VR Buchholz","year":"2013","unstructured":"Buchholz VR, Flossdorf M, Hensel I, Kretschmer L, Weissbrich B, Gr\u00e4f P et al. Disparate individual fates compose robust CD8+ T cell immunity. Science 2013; 340: 630\u2013635.","journal-title":"Science"},{"key":"BFleu201716_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1182\/blood-2014-06-578989","volume":"124","author":"NP Restifo","year":"2014","unstructured":"Restifo NP . Big bang theory of stem-like T cells confirmed. Blood 2014; 124: 476\u2013477.","journal-title":"Blood"},{"key":"BFleu201716_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","volume":"110","author":"T Haque","year":"2007","unstructured":"Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P et al. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 2007; 110: 1123\u20131131.","journal-title":"Blood"},{"key":"BFleu201716_CR17","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/cid\/cis625","volume":"55","author":"M Uhlin","year":"2012","unstructured":"Uhlin M, Gertow J, Uzunel M, Okas M, Berglund S, Watz E et al. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease. Clin Infect Dis 2012; 55: 1064\u20131073.","journal-title":"Clin Infect Dis"},{"key":"BFleu201716_CR18","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","volume":"116","author":"JN Barker","year":"2010","unstructured":"Barker JN, Doubrovina E, Sauter C, Jaroscak JJ, Perales MA, Doubrovin M et al. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood 2010; 116: 5045\u20135049.","journal-title":"Blood"},{"key":"BFleu201716_CR19","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","volume":"121","author":"AM Leen","year":"2013","unstructured":"Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH et al. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 2013; 121: 5113\u20135123.","journal-title":"Blood"},{"key":"BFleu201716_CR20","doi-asserted-by":"publisher","first-page":"e61384","DOI":"10.1371\/journal.pone.0061384","volume":"8","author":"G D\u00f6ssinger","year":"2013","unstructured":"D\u00f6ssinger G, Bunse M, Bet J, Albrecht J, Paszkiewicz PJ, Weissbrich B et al. MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy. PLoS ONE 2013; 8: e61384.","journal-title":"PLoS ONE"},{"key":"BFleu201716_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","volume":"21","author":"G Koehne","year":"2015","unstructured":"Koehne G, Hasan A, Doubrovina E, Prockop S, Tyler E, Wasilewski G et al. Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia. Biol Blood Marrow Transplant 2015; 21: 1663\u20131678.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu201716_CR22","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","volume":"121","author":"E Blyth","year":"2013","unstructured":"Blyth E, Clancy L, Simms R, Ma CKK, Burgess J, Deo S et al. Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood 2013; 121: 3745\u20133758.","journal-title":"Blood"},{"key":"BFleu201716_CR23","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1086\/648422","volume":"49","author":"KS Peggs","year":"2009","unstructured":"Peggs KS, Verfuerth S, Pizzey A, Chow S-LC, Thomson K, Mackinnon S . Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation. Clin Infect Dis 2009; 49: 1851\u20131860.","journal-title":"Clin Infect Dis"},{"key":"BFleu201716_CR24","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","volume":"125","author":"J Feucht","year":"2015","unstructured":"Feucht J, Opherk K, Lang P, Kayser S, Hartl L, Bethge W et al. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. Blood 2015; 125: 1986\u20131994.","journal-title":"Blood"},{"key":"BFleu201716_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","volume":"11","author":"FM Marty","year":"2011","unstructured":"Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis 2011; 11: 284\u2013292.","journal-title":"Lancet Infect Dis"},{"key":"BFleu201716_CR26","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1172\/JCI45449","volume":"121","author":"M Boeckh","year":"2011","unstructured":"Boeckh M, Geballe AP . Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 2011; 121: 1673\u20131680.","journal-title":"J Clin Invest"},{"key":"BFleu201716_CR27","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1172\/JCI81229","volume":"125","author":"M Bleakley","year":"2015","unstructured":"Bleakley M, Heimfeld S, Loeb KR, Jones LA, Chaney C, Seropian S et al. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts. J Clin Invest 2015; 125: 2677\u20132689.","journal-title":"J Clin Invest"},{"key":"BFleu201716_CR28","doi-asserted-by":"publisher","first-page":"e35798","DOI":"10.1371\/journal.pone.0035798","volume":"7","author":"C Stemberger","year":"2012","unstructured":"Stemberger C, Dreher S, Tschulik C, Piossek C, Bet J, Yamamoto TN et al. Novel serial positive enrichment technology enables clinical multiparameter cell sorting. PLoS ONE 2012; 7: e35798.","journal-title":"PLoS ONE"},{"key":"BFleu201716_CR29","first-page":"410","volume":"3","author":"B Eiz-Vesper","year":"2012","unstructured":"Eiz-Vesper B, Maecker-Kolhoff B, Blasczyk R . Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry. Front Immunol 2012; 3: 410.","journal-title":"Front Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201716","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/leu201716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:33:21Z","timestamp":1648748001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFleu201716"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.16","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"3 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LG is an employee of and holds shares in Stage Cell Therapeutics, G\u00f6ttingen, Germany; now Juno Therapeutics GmbH, Munich, Germany. DHB invented the Streptamer technology and holds shares of Juno Cell Therapeutics Inc. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}